财联社6月8日电,罗氏发表声明称,已与生物制药公司Nurix Therapeutics达成独家许可与合作协议。罗氏将支付最高23亿美元,以获得Nurix一种实验性血液癌症药物的权益。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.